|
|
|
|
|
|
|
Hutchison China MediTech Limited (HCM)
|
|
30.16 -6.44 (-17.6%)
|
11-16 16:00
|
|
Open:
|
31.34
|
Pre. Close:
|
36.6
|
|
High:
|
31.34
|
Low:
|
26
|
|
Volume:
|
1,784,281
|
Market Cap:
|
3846M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
31.353 - 31.564
|
31.564 - 31.739
|
|
Low:
|
25.657 - 25.831
|
25.831 - 25.976
|
|
Close:
|
29.865 - 30.192
|
30.192 - 30.463
|
|
|
|
Technical analysis (as of: 2018-11-16 4:34:08 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a STRONG SELL today, downgraded from higher rating. This stock seems to be very strong for short side. So you may continue to hold the short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.
|
|
Target:
|
Six months: 40.24 One year: 46.35
|
|
Support:
|
Support1: 26.00 Support2: 21.63
|
|
Resistance:
|
Resistance1:
34.45 Resistance2: 39.68
|
|
Pivot:
|
32.57 
|
|
Moving Averages:
|
MA(5): 33.67 MA(20): 31.89
MA(100): 30.74 MA(250): 32.54
|
|
MACD:
|
MACD(12,26):
0.91 Signal(12,26,9): 0.80
|
|
%K %D:
|
%K(14,3): 61.37 %D(3): 72.28
|
|
RSI:
|
RSI(14): 44.64
|
|
52-Week:
|
High: 42.254
Low: 25.76 Change(%): -11.9
|
|
Average Vol(K):
|
3-Month: 20541
10-Days 52691
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.HCM has closed above bottom band by 19.7%. Bollinger Bands are 83.2% wider than normal. The large width of the bands suggest high volatility as compared to HCM's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
2018-11-16T12:46:49-05:00
NVIDIA , Gogo, PG&E and Sphere 3D among midday movers
2018-11-16T11:45:28-05:00
Chi-Med down 21% on failed study of fruquintinib in lung cancer
2018-11-16T06:30:27-05:00
Chi-Med's phase III FALUCA trial for fruquintinib fails to meet primary endpoint; shares down 17% premarket
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
